What is MedRhythms?
MedRhythms operates at the intersection of neurology and digital therapeutics, specializing in Neurologic Music Therapy (NMT). Since its inception in 2015, the organization has developed a robust framework for treating patients suffering from traumatic brain injuries, strokes, and neurodegenerative conditions. By leveraging the neurological response to rhythmic auditory stimulation, MedRhythms provides evidence-based interventions that address sensorimotor, speech, and cognitive deficits.
The company maintains a strategic footprint through partnerships with premier rehabilitation hospitals, delivering care across diverse modalities including telehealth, in-home, and community-based settings. This multi-channel delivery model positions MedRhythms as a scalable player in the neuro-recovery market, effectively addressing the growing demand for non-pharmacological, technology-driven therapeutic interventions.
How much funding has MedRhythms raised?
MedRhythms has raised a total of $5.7M across 3 funding rounds:
Series A
$5.3M
Debt
$150K
Debt
$272K
Series A (2018): $5.3M, investors not publicly disclosed
Debt (2020): $150K led by PPP
Debt (2021): $272K supported by PPP
Key Investors in MedRhythms
PPP
Public-Private Partnership
Undisclosed Investor
A strategic partner or venture firm focused on early-stage investments in the digital health and neuro-technology sectors.
Undisclosed Investor
An undisclosed investor participating in the funding round to support the advancement of clinical neurorehabilitation technologies.
What's next for MedRhythms?
With the recent influx of capital, MedRhythms is well-positioned to accelerate its clinical research initiatives and broaden its geographic footprint. The strategic focus will likely shift toward enhancing its digital platform capabilities to support wider telehealth adoption and deepening its integration within the existing healthcare ecosystem. As the company transitions into its next phase of growth, the emphasis remains on clinical validation and the expansion of its NMT service offerings to meet the complex needs of patients across the continuum of care. Future milestones will likely involve scaling its provider network and refining its proprietary algorithms to optimize patient outcomes in neuro-rehabilitation.
See full MedRhythms company page
